IRIS
ZICHE, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.683
EU - Europa 12.788
AS - Asia 7.640
SA - Sud America 1.254
AF - Africa 260
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 6
Totale 39.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.513
GB - Regno Unito 3.535
CN - Cina 2.732
SG - Singapore 2.281
RU - Federazione Russa 2.179
IE - Irlanda 1.776
UA - Ucraina 1.242
BR - Brasile 1.066
SE - Svezia 1.038
VN - Vietnam 855
FR - Francia 814
IT - Italia 725
DE - Germania 718
HK - Hong Kong 595
KR - Corea 418
FI - Finlandia 403
IN - India 248
TR - Turchia 97
CA - Canada 82
ZA - Sudafrica 78
AR - Argentina 76
BD - Bangladesh 72
ES - Italia 68
IQ - Iraq 58
NG - Nigeria 55
MX - Messico 53
NL - Olanda 50
PL - Polonia 45
BE - Belgio 44
ID - Indonesia 35
JP - Giappone 34
CI - Costa d'Avorio 32
PK - Pakistan 30
EC - Ecuador 28
AT - Austria 25
MA - Marocco 25
SA - Arabia Saudita 23
KE - Kenya 20
NP - Nepal 19
UZ - Uzbekistan 19
VE - Venezuela 19
AU - Australia 18
CO - Colombia 18
CL - Cile 17
DZ - Algeria 17
LT - Lituania 15
IL - Israele 13
JO - Giordania 13
PH - Filippine 13
BG - Bulgaria 12
CZ - Repubblica Ceca 12
PY - Paraguay 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
EG - Egitto 9
AZ - Azerbaigian 8
BY - Bielorussia 8
PE - Perù 8
PT - Portogallo 8
GR - Grecia 7
KG - Kirghizistan 7
MY - Malesia 7
AM - Armenia 6
DK - Danimarca 6
EE - Estonia 6
EU - Europa 6
HU - Ungheria 6
OM - Oman 6
UY - Uruguay 6
AL - Albania 5
CR - Costa Rica 5
IR - Iran 5
SN - Senegal 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GT - Guatemala 4
JM - Giamaica 4
KH - Cambogia 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AO - Angola 3
CH - Svizzera 3
CY - Cipro 3
HN - Honduras 3
HR - Croazia 3
LB - Libano 3
MM - Myanmar 3
MN - Mongolia 3
SY - Repubblica araba siriana 3
DM - Dominica 2
GE - Georgia 2
Totale 39.626
Salva come PNG Salva come JPEG
Città #
Southend 3.222
Fairfield 1.982
Dallas 1.890
Dublin 1.759
Singapore 1.375
Ashburn 1.357
Chandler 1.068
Jacksonville 1.007
Woodbridge 939
Houston 889
Seattle 799
Wilmington 782
Cambridge 679
Moscow 585
Hong Kong 567
San Jose 546
Beijing 538
Santa Clara 520
Ann Arbor 464
Hefei 454
Seoul 417
Princeton 363
The Dalles 337
Nanjing 312
Ho Chi Minh City 236
Los Angeles 217
Siena 205
Hanoi 189
Lauterbourg 186
Boardman 160
San Diego 152
Helsinki 150
Menlo Park 148
Council Bluffs 137
Nanchang 126
San Mateo 115
Dong Ket 108
New York 107
Columbus 103
Buffalo 102
Fremont 101
Pune 85
Tianjin 85
São Paulo 79
Shenyang 74
Munich 73
Kunming 67
Izmir 63
Johannesburg 57
Bengaluru 55
Hebei 52
Redondo Beach 52
Abuja 51
London 51
Orem 49
Florence 47
Da Nang 46
Changsha 45
Brussels 44
Turku 43
Jinan 40
Milan 39
Shanghai 39
Warsaw 39
Zhengzhou 38
Dearborn 37
San Francisco 37
Málaga 36
Norwalk 35
Toronto 35
Abidjan 32
Rome 32
Chennai 31
Chicago 31
Frankfurt am Main 31
Atlanta 30
Düsseldorf 30
Haiphong 30
Jiaxing 30
Falls Church 29
Lancaster 29
Tokyo 28
Amsterdam 27
Brooklyn 27
Hangzhou 27
Nuremberg 27
Redwood City 27
Guangzhou 26
Belo Horizonte 23
Rio de Janeiro 23
Stockholm 23
Poplar 22
Phoenix 20
Jakarta 19
Mexico City 19
Ningbo 19
Denver 18
Manchester 18
Nairobi 18
Taizhou 18
Totale 27.650
Salva come PNG Salva come JPEG
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 435
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 414
A fucose-containing O-glycoepitope on bovine and human nucleolin 380
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 344
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 325
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 307
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 299
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 295
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 293
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 293
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 293
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 289
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 284
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 270
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 265
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 261
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 257
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 256
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 252
Divergent effects of quercetin conjugates on angiogenesis 251
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 251
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 249
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 248
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 248
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 247
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 247
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 245
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 244
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 242
Analysis of the role of chemokines in angiogenesis 239
Biological characterization of nanocomposite hydrogels 238
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 237
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 237
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 231
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 231
Studying vascular angiogenesis and senescence in zebrafish embryos 231
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 231
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 231
Activity of "NO-donor" or "NO-mediated" drugs 230
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 227
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 227
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 222
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 221
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 218
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 217
Absence of PAF actions increases angiogenesis 214
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through a5b1 integrin 213
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 211
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 210
Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1α expression in an AhR-independent fashion 209
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 208
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 208
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 208
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 207
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 207
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 206
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 205
Assessing vascular senescence in zebrafish 205
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 205
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 205
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 203
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 203
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 203
Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. 202
Role of nitric oxide in the modulation of angiogenesis 201
Differential contribution of bradykinin receptors in angiogenesis 200
The rabbit corneal pocket assay 197
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 196
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 195
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 195
Angiogenesis 195
Activation of MAPK in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats 194
Nitric oxide in tumor angiogenesis 192
Role of prostaglandin E1 and copper in angiogenesis 192
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 190
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 189
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells 188
Molecular mechanisms of resistance to anti-angiogenic drugs 188
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 187
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 187
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 186
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 184
New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis 184
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 183
In vitro and in vivo models to study chemokine regulation of angiogenesis 181
The corneal pocket assay 181
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 180
Nitric oxide and angiogenesis 180
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses 179
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 179
Inflammation and tumor progression: role of prostaglandin E2 pathway 176
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 174
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 174
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 173
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 173
Repurposing of drugs for triple negative breast cancer: an overview 171
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 170
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 170
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 169
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 169
Totale 22.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021932 0 0 0 0 0 0 0 0 0 287 312 333
2021/20222.838 187 392 153 349 122 120 133 122 105 327 245 583
2022/20233.805 248 272 497 589 387 778 51 288 406 69 125 95
2023/20242.371 115 50 155 187 62 696 835 56 3 26 16 170
2024/20254.812 88 292 407 301 452 193 95 298 347 216 606 1.517
2025/202611.090 1.022 1.804 1.417 1.218 2.255 478 1.632 299 460 505 0 0
Totale 39.882